MXCT vs PDD · rev $38.6M vs P/E 8.4, rev $61.75B
MaxCyte Inc (MXCT) versus PDD Holdings Inc. (PDD) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
PDD Holdings Inc. (PDD) is a internet retail company listed on NASDAQ.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported PDD revenue for 2025-12-31 was $61.75B. Net income was $13.99B. Revenue was up 14.5% from 2024-12-31 to 2025-12-31. PDD currently screens at market cap $113.67B and trailing P/E 8.4.
MXCT currently screens at market cap $124.3M. PDD currently screens at market cap $113.67B and trailing P/E 8.4.
Not investment advice. Open the MXCT and PDD stock pages for the full models.
Not investment advice.